Amneal Pharmaceuticals, Inc.AMRXNASDAQ

Revenue (LTM)

$3.0B

+8.0% YoY

Net Income (LTM)

$72M

+161.6% YoY

Free Cash Flow

$270M

Revenue CAGR (5Y)

+8.7%

—Marginsstable

FCF$0.3B

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	2,094	2,212↑5.7%	2,394↑8.2%	2,794↑16.7%	3,019↑8.0%
Gross Profit	769	791↑2.9%	864↑9.1%	1,020↑18.1%	1,136↑11.3%
Operating Income	153	-95↓162.2%	204↑315.3%	249↑22.0%	423↑69.7%
Net Income	11	-130↓1323.5%	-84↑35.4%	-117↓39.2%	72↑161.6%
EBITDA	401	440↑9.8%	501↑13.8%	440↓12.2%	604↑37.3%
EPS Diluted	0.07	-0.86↓1328.6%	-0.48↑44.2%	-0.38↑20.8%	0.22↑157.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	248	26↓89.5%	92↑252.4%	111↑20.8%	311↑181.2%
Total Current Assets	1,520	1,412↓7.1%	1,378↓2.4%	1,588↑15.2%	1,911↑20.4%
Total Assets	3,940	3,799↓3.6%	3,473↓8.6%	3,501↑0.8%	3,678↑5.1%
Total Current Liabilities	677	753↑11.2%	847↑12.5%	1,130↑33.4%	882↓22.0%
Total Liabilities	3,573	3,590↑0.5%	3,411↓5.0%	3,546↑3.9%	3,672↑3.6%
Total Equity	360	298↓17.2%	20↓93.4%	-109↓652.4%	-71↑35.2%
Total Debt	2,876	2,845↓1.1%	2,751↓3.3%	2,593↓5.7%	2,736↑5.5%
Net Debt	2,628	2,819↑7.3%	2,659↓5.7%	2,483↓6.6%	2,426↓2.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	242	65↓73.1%	346↑430.8%	295↓14.6%	340↑15.2%
Capital Expenditure	-48	-91↓89.8%	-69↑23.6%	-75↓8.4%	-70↑6.6%
Free Cash Flow	194	-25↓113.1%	276↑1184.1%	220↓20.4%	270↑22.6%
Stock-Based Comp	0	32	27↓15.8%	28↑3.5%	32↑15.1%
Net Change in Cash	-90	-222↓145.1%	64↑128.8%	19↓69.8%	195↑907.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance